Skip to main content
SpringerLink
Log in

Preoperative and Postoperative Medical Management for Rheumatoid Hand Surgery

  • Chapter
  • First Online:
Clinical Management of the Rheumatoid Hand, Wrist, and Elbow

  • 1242 Accesses

Abstract

Rheumatoid arthritis (RA) is a progressive disease of joint inflammation with systemic and extra-articular features. The evolving understanding of its pathogenesis has led to revolutionary development of targeted therapy that is changing its course and associated morbidity and mortality. Nevertheless, a substantial number of patients will experience progression of their disease leading to disability. Reconstructive hand surgery remains an important complimentary therapeutic option in restoring function and improving quality of life for patients with RA. Preoperative management of the disease and comorbidities is critical in optimizing the surgical outcome. Postoperative wound and joint infections remain a serious concern and can be minimized by reducing the intensity of immunosuppression. A multidisciplinary approach involving the surgeons, rheumatologists, primary care physicians, anesthesiologists, radiologists, and rehabilitation specialist is essential for a successful outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kapetanovic MC, et al. Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: prevalence and predictive factors of large joint replacement. Ann Rheum Dis. 2008;67(10):1412–6.

    Article  CAS  PubMed  Google Scholar 

  2. Massardo L, et al. A population based assessment of the use of orthopedic surgery in patients with rheumatoid arthritis. J Rheumatol. 2002;29(1):52–6.

    PubMed  Google Scholar 

  3. de la Mata Llord J, Palacios Carvajal J. Rheumatoid arthritis: are outcomes better with medical or surgical management? Orthopedics. 1998;21(10):1085–6.

    PubMed  Google Scholar 

  4. Doran MF, et al. Predictors of infection in rheumatoid arthritis. Arthritis Rheum. 2002;46(9):2294–300.

    Article  PubMed  Google Scholar 

  5. Berbari EF, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998;27(5):1247–54.

    Article  CAS  PubMed  Google Scholar 

  6. Smitten AL, et al. The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol. 2008;35(3):387–93.

    PubMed  Google Scholar 

  7. Waters RV, et al. Systemic corticosteroids inhibit bone healing in a rabbit ulnar osteotomy model. Acta Orthop Scand. 2000;71(3):316–21.

    Article  CAS  PubMed  Google Scholar 

  8. Cross SE, et al. An experimental model to investigate the dynamics of wound contraction. Br J Plast Surg. 1995;48(4):189–97.

    Article  CAS  PubMed  Google Scholar 

  9. Del Rio JV, et al. Chronic perioperative steroids and colonic anastomotic healing in rats. J Surg Res. 1996;66(2):138–42.

    Article  PubMed  Google Scholar 

  10. Cohen SC, et al. Effects of antineoplastic agents on wound healing in mice. Surgery. 1975;78(2):238–44.

    CAS  PubMed  Google Scholar 

  11. Shamberger RC, Devereux DF, Brennan MF. The effect of chemotherapeutic agents on wound healing. Int Adv Surg Oncol. 1981;4:15–58.

    CAS  PubMed  Google Scholar 

  12. Grennan DM, et al. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis. 2001;60(3):214–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Garner RW, Mowat AG, Hazleman BL. Post-operative wound healing in patients with rheumatoid arthritis. Ann Rheum Dis. 1973;32(3):273–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Perhala RS, et al. Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum. 1991;34(2):146–52.

    Article  CAS  PubMed  Google Scholar 

  15. Jain A, et al. Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery. J Hand Surg [Am]. 2002;27(3):449–55.

    Article  Google Scholar 

  16. Kasdan ML, June L. Postoperative results of rheumatoid arthritis patients on methotrexate at the time of reconstructive surgery of the hand. Orthopedics. 1993;16(11):1233–5.

    CAS  PubMed  Google Scholar 

  17. Sany J, et al. Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatol. 1993;20(7):1129–32.

    CAS  PubMed  Google Scholar 

  18. Iglesias E, et al. Effect of blockade of tumor necrosis factor-alpha with etanercept on surgical wound healing in SWISS-OF1 mice. J Rheumatol. 2009;36(10):2144–8.

    Article  CAS  PubMed  Google Scholar 

  19. Ashcroft GS, et al. Tumor necrosis factor-alpha (TNF-alpha) is a therapeutic target for impaired cutaneous wound healing. Wound Repair Regen. 2012;20(1):38–49.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Sandberg O, et al. Etanercept does not impair healing in rat models of tendon or metaphyseal bone injury. Acta Orthop. 2012;83(3):305–10.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Elder CL, et al. A cyclooxygenase-2 inhibitor impairs ligament healing in the rat. Am J Sports Med. 2001;29(6):801–5.

    CAS  PubMed  Google Scholar 

  22. Virchenko O, et al. Parecoxib impairs early tendon repair but improves later remodeling. Am J Sports Med. 2004;32(7):1743–7.

    Article  PubMed  Google Scholar 

  23. Collins DN, et al. Cervical spine instability in rheumatoid patients having total hip or knee arthroplasty. Clin Orthop Relat Res. 1991;272:127–35.

    PubMed  Google Scholar 

  24. Kwek TK, et al. The role of preoperative cervical spine X-rays in rheumatoid arthritis. Anaesth Intensive Care. 1998;26(6):636–41.

    CAS  PubMed  Google Scholar 

  25. Neva MH, et al. High prevalence of asymptomatic cervical spine subluxation in patients with rheumatoid arthritis waiting for orthopaedic surgery. Ann Rheum Dis. 2006;65(7):884–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Zikou AK, et al. Radiological cervical spine involvement in patients with rheumatoid arthritis: a cross sectional study. J Rheumatol. 2005;32(5):801–6.

    PubMed  Google Scholar 

  27. Boden SD, et al. Rheumatoid arthritis of the cervical spine. A long-term analysis with predictors of paralysis and recovery. J Bone Joint Surg Am. 1993;75(9):1282–97.

    CAS  PubMed  Google Scholar 

  28. Voulgari PV, et al. Laryngeal involvement in rheumatoid arthritis. Rheumatol Int. 2005;25(5):321–5.

    Article  CAS  PubMed  Google Scholar 

  29. Peters JE, et al. Three cases of rheumatoid arthritis with laryngeal stridor. Clin Rheumatol. 2011;30(5):723–7.

    Article  PubMed  Google Scholar 

  30. Kolman J, Morris I. Cricoarytenoid arthritis: a cause of acute upper airway obstruction in rheumatoid arthritis. Can J Anaesth. 2002;49(7):729–32.

    Article  PubMed  Google Scholar 

  31. O’Dwyer DN, et al. Rheumatoid arthritis (RA) associated interstitial lung disease (ILD). Eur J Intern Med. 2013;24(7):597–603.

    Article  PubMed  Google Scholar 

  32. Restrepo JF, et al. Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis. Clin Rheumatol. 2015; 34:1529–1536

    Google Scholar 

  33. Suzuki A, et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol. 1994;21(1):33–6.

    CAS  PubMed  Google Scholar 

  34. Lindhardsen J, et al. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis. 2011;70(6):929–34.

    Article  PubMed  Google Scholar 

  35. Meune C, et al. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford). 2009;48(10):1309–13.

    Article  Google Scholar 

  36. del Rincon ID, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44(12):2737–45.

    Article  PubMed  Google Scholar 

  37. Fleisher LA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007;116(17):e418–99.

    Article  PubMed  Google Scholar 

  38. Hlatky MA, et al. A brief self-administered questionnaire to determine functional capacity (the duke activity status index). Am J Cardiol. 1989;64(10):651–4.

    Article  CAS  PubMed  Google Scholar 

  39. Akkara Veetil BM, Bongartz T. Perioperative care for patients with rheumatic diseases. Nat Rev Rheumatol. 2012;8(1):32–41.

    Article  CAS  Google Scholar 

  40. Kirwan JR, et al. The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54(5):1415–21.

    Article  CAS  PubMed  Google Scholar 

  41. Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. JAMA. 2002;287(2):236–40.

    Article  CAS  PubMed  Google Scholar 

  42. Thomason JM, et al. An investigation into the need for supplementary steroids in organ transplant patients undergoing gingival surgery. A double-blind, split-mouth, cross-over study. J Clin Periodontol. 1999;26(9):577–82.

    Article  CAS  PubMed  Google Scholar 

  43. Glowniak JV, Loriaux DL. A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency. Surgery. 1997;121(2):123–9.

    Article  CAS  PubMed  Google Scholar 

  44. Bromberg JS, et al. Stress steroids are not required for patients receiving a renal allograft and undergoing operation. J Am Coll Surg. 1995;180(5):532–6.

    CAS  PubMed  Google Scholar 

  45. Marik PE, Varon J. Requirement of perioperative stress doses of corticosteroids: a systematic review of the literature. Arch Surg. 2008;143(12):1222–6.

    Article  CAS  PubMed  Google Scholar 

  46. Friedman RJ, et al. Use of supplemental steroids in patients having orthopaedic operations. J Bone Joint Surg Am. 1995;77(12):1801–6.

    CAS  PubMed  Google Scholar 

  47. Haugeberg G, et al. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum. 2000;43(3):522–30.

    Article  CAS  PubMed  Google Scholar 

  48. Joffe I, Epstein S. Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. Semin Arthritis Rheum. 1991;20(4):256–72.

    Article  CAS  PubMed  Google Scholar 

  49. Gao Y, et al. The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials. 2009;30(9):1790–6.

    Article  CAS  PubMed  Google Scholar 

  50. Shanbhag AS. Use of bisphosphonates to improve the durability of total joint replacements. J Am Acad Orthop Surg. 2006;14(4):215–25.

    PubMed  Google Scholar 

  51. Matuszewski L, et al. Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using micro-computed tomography. Int Orthop. 2013;37(6):1187–93.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Caplan L, et al. Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomes. J Rheumatol. 2007;34(4):696–705.

    PubMed  Google Scholar 

  53. Dixon WG, et al. The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses. Arthritis Res Ther. 2011;13(4):R139.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Goodman SM, et al. Patients with rheumatoid arthritis are more likely to have pain and poor function after total hip replacements than patients with osteoarthritis. J Rheumatol. 2014;41(9):1774–80.

    Article  PubMed  Google Scholar 

  55. Maderazo EG, et al. Late infections of total joint prostheses. A review and recommendations for prevention. Clin Orthop Relat Res. 1988;229:131–42.

    PubMed  Google Scholar 

  56. Bridges Jr SL, et al. Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J Rheumatol. 1991;18(7):984–8.

    PubMed  Google Scholar 

  57. Carpenter MT, et al. Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics. 1996;19(3):207–10.

    CAS  PubMed  Google Scholar 

  58. Steuer A, Keat AC. Perioperative use of methotrexate—a survey of clinical practice in the UK. Br J Rheumatol. 1997;36(9):1009–11.

    Article  CAS  PubMed  Google Scholar 

  59. Escalante A, Beardmore TD. Risk factors for early wound complications after orthopedic surgery for rheumatoid arthritis. J Rheumatol. 1995;22(10):1844–51.

    CAS  PubMed  Google Scholar 

  60. Murata K, et al. Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Mod Rheumatol. 2006;16(1):14–9.

    Article  CAS  PubMed  Google Scholar 

  61. Barnard AR, et al. Wound healing with medications for rheumatoid arthritis in hand surgery. ISRN Rheumatol. 2012;2012:251962.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Jenks KA, et al. Leflunomide-associated infections in rheumatoid arthritis. J Rheumatol. 2007;34(11):2201–3.

    CAS  PubMed  Google Scholar 

  63. Fuerst M, et al. Leflunomide increases the risk of early healing complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Rheumatol Int. 2006;26(12):1138–42.

    Article  CAS  PubMed  Google Scholar 

  64. Tanaka N, et al. Examination of the risk of continuous leflunomide treatment on the incidence of infectious complications after joint arthroplasty in patients with rheumatoid arthritis. J Clin Rheumatol. 2003;9(2):115–8.

    Article  PubMed  Google Scholar 

  65. Bibbo C. Wound healing complications and infection following surgery for rheumatoid arthritis. Foot Ankle Clin. 2007;12(3):509–24. vii.

    Article  PubMed  Google Scholar 

  66. Pieringer H, et al. Patients with rheumatoid arthritis undergoing surgery: how should we deal with antirheumatic treatment? Semin Arthritis Rheum. 2007;36(5):278–86.

    Article  PubMed  Google Scholar 

  67. Bongartz T, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006;295(19):2275–85.

    Article  CAS  PubMed  Google Scholar 

  68. Hirano Y, et al. Influences of anti-tumour necrosis factor agents on postoperative recovery in patients with rheumatoid arthritis. Clin Rheumatol. 2010;29(5):495–500.

    Article  PubMed  Google Scholar 

  69. Ruyssen-Witrand A, et al. Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. Clin Exp Rheumatol. 2007;25(3):430–6.

    CAS  PubMed  Google Scholar 

  70. Talwalkar SC, et al. Tumour necrosis factor alpha antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery. Ann Rheum Dis. 2005;64(4):650–1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Johnson BK, et al. Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement. J Rheumatol. 2013;40(5):617–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Kubota A, et al. Perioperative complications in elective surgery in patients with rheumatoid arthritis treated with biologics. Mod Rheumatol. 2012;22(6):844–8.

    Article  PubMed  Google Scholar 

  73. Wendling D, et al. Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures. Ann Rheum Dis. 2005;64(9):1378–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Kawakami K, et al. Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-alpha blockers: perioperative interruption of tumour necrosis factor-alpha blockers decreases complications? Rheumatology (Oxford). 2010;49(2):341–7.

    Article  CAS  Google Scholar 

  75. Giles JT, et al. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum. 2006;55(2):333–7.

    Article  PubMed  Google Scholar 

  76. Momohara S, et al. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs. Mod Rheumatol. 2011;21(5):469–75.

    Article  PubMed  Google Scholar 

  77. Goodman S, et al. Management of perioperative tumor necrosis alpha inhibitors in rheumatoid arthritis undergoing arthroplasty: a systematic review and meta-analysis. Arthritis Rheumatol. 2014;66(11):S1031.

    Google Scholar 

  78. Saag KG, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59(6):762–84.

    Article  CAS  PubMed  Google Scholar 

  79. Zimmerli W, Moser C. Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol. 2012;65(2):158–68.

    Article  CAS  PubMed  Google Scholar 

  80. Gottenberg JE, et al. Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis Rheum. 2010;62(9):2625–32.

    Article  CAS  PubMed  Google Scholar 

  81. Godot S, et al. Safety of surgery after rituximab therapy in 133 patients with rheumatoid arthritis: data from the autoimmunity and rituximab registry. Arthritis Care Res (Hoboken). 2013;65(11):1874–9.

    Article  CAS  Google Scholar 

  82. Kremer JM, et al. Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial. J Rheumatol. 2014;41(6):1077–87.

    Article  CAS  PubMed  Google Scholar 

  83. Hirao M, et al. Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab. Ann Rheum Dis. 2009;68(5):654–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Galloway JB, et al. The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford). 2011;50(7):1341–2.

    Article  Google Scholar 

  85. Wollenhaupt J, et al. Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, for the treatment of rheumatoid arthritis in open-label, long term extension studies. J Rheumatol. 2014;41(5):837–52.

    Article  CAS  PubMed  Google Scholar 

  86. Cohen S, et al. Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014;66(11):2924–37.

    Article  CAS  PubMed  Google Scholar 

  87. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med. 1994;330(18):1287–94.

    Article  CAS  PubMed  Google Scholar 

  88. Diaz-Gonzalez F, Sanchez-Madrid F. NSAIDs: learning new tricks from old drugs. Eur J Immunol. 2015;45(3):679–86.

    Article  CAS  PubMed  Google Scholar 

  89. Cronberg S, et al. Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans. Scand J Haematol. 1984;33(2):155–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internal Medicine, Division of Rheumatology, University of Michigan, 300 North Ingalls Street, Suite 7C27, Ann Arbor, MI, 48109-5422, USA

    Vladimir M. Ognenovski MD

Authors
  1. Vladimir M. Ognenovski MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vladimir M. Ognenovski MD .

Editor information

Editors and Affiliations

  1. Comp Hand Cen. Sec of PS, Dept of Surg, The University of Michigan Health System, Ann Arbor, Michigan, USA

    Kevin C. Chung

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ognenovski, V.M. (2016). Preoperative and Postoperative Medical Management for Rheumatoid Hand Surgery. In: Chung, K. (eds) Clinical Management of the Rheumatoid Hand, Wrist, and Elbow. Springer, Cham. https://doi.org/10.1007/978-3-319-26660-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26660-2_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26658-9

  • Online ISBN: 978-3-319-26660-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation